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Letter to the Editor
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Reply to Akilen et al. Effect of cinnamon on
glycated haemoglobin and blood pressure
Diabet. Med. 28, 380 (2011)
We read, with interest, the article of Akilen et al. [1], in which the
authors describe their investigation of the effects of 2 g of
cinnamon in a randomized, placebo-controlled, double-blind
trial. Without doubt, this study adds to the limited existing
evidence, which up to now is mostly of poor methodological
quality [2]. A recent meta-analysis showed that the overall effect
of cinnamon on HbA1c was 0.0% (95% CI –0.2 to 0.2)
(0 mmol ⁄mol; 95% CI –2 to 2), therefore this study does give
some new hope for the effectiveness of cinnamon [3].
However, we have some concerns regarding the
methodological quality and the external validity of this study.
Firstly, it was stated in the article that the double blinding was
ensured, for example, by matching the smell of the placebo and
the cinnamon capsules. However, later on, it was stated that the
placebo capsules were given the same aroma by placing
cinnamon powder under the lid of only the placebo bottles. At
the least, this potentially causes problems with the blinding of the
researchers, especially with regard to the capsule count at week 6
of the study. Secondly, it is unclear whether the dosage of oral
blood glucose-lowering agents could be altered. This study was
conducted in a young population with an HbA1c of ‡ 7%
(53 mmol ⁄mol). Mean HbA1c, for example, in the placebo
group was 8.6% (70 mmol ⁄mol) with a standard deviation of
1.8% (19 mmol ⁄mol). This implies that distribution is skewed
and that a median and interquartile range would be more
informative, but this also means that a considerable proportion
of patients might have had an HbA1c measurement above 10%
(86 mmol ⁄mol), especially in the placebo group. Thirdly, there
are some non-significant baseline differences and changes
between groups; however, these differences could have some
relevance and could be non-significant only because of the small
sample size. For example, in the cinnamon group at baseline,
mean BMI is higher by 1.2 kg ⁄m2. Body weight declines
throughout the study by 2.9 kg, compared with 0.5 kg in the
placebo group. This difference in change of body weight can only
partly be explained from the differences in total energy intake. In
our view, it would have been informative to adjust differences in
HbA1c change for changes in bodyweight and ⁄or total energy
intake in their analyses and to report the size of these effects, not
only to see whether the influence is significant or not. Apart from
reporting confidence intervals for within-group effects,
especially between group effects together with a 95% CI,
adjusted and unadjusted for weight change, it is essential to be
able to interpret the placebo-controlled effects of cinnamon.
Fourthly, details regarding the predefined hypothesis and power
calculation are, unfortunately, lacking. Lastly, because
cinnamon contains many different components, the safety of
high-dose cinnamon intake should be given more attention in
future trials, as teratogenic and carcinogenic effects have been
found in animal studies and case reports of certain components
[2]. Furthermore, coumarin is one of the components of
cinnamon and coagulation parameters should be part of the
assessments of future trials.
Although this study gives some hope regarding the
effectiveness of cinnamon, this should be confirmed in other,
also well-performed trials. Furthermore, safety concerns
regarding high-dose cinnamon remain, so, in our view, it is too
premature to state (as the authors did) that cinnamon
supplementation could be considered as an additional dietary
supplement option in patients with Type 2 diabetes.
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